Alliance Global analyst Aaron Grey lowered the firm’s price target on Tilray (TLRY) to $10 from $20 and keeps a Neutral rating on the shares. Tilray reported Q2 sales above the firm’s and Street estimates, driven by higher distribution revenue and international sales, with EBITDA coming in slightly above the firm’s Street-matching $7.9M estimate, the analyst tells investors. The firm views the quarter as in-line on a consolidated basis with some strengths offsetting some weaknesses, but remains on the sidelines as it looks for greater transparency to long-term sales and cash flow, the analyst added.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- TLRY Earnings: Tilray Stock Jumps 8% on Record Quarterly Revenue
- Tilray reports Q2 adjusted EPS (2c) vs. (3c) last year
- Tilray options imply 10.0% move in share price post-earnings
- Options Volatility and Implied Earnings Moves Today, January 08, 2026
- Tilray (TLRY) Is About to Report Q2 Earnings. Here’s What to Expect from the Cannabis Stock